143 related articles for article (PubMed ID: 17018602)
1. Regulation of hdm2 by stress-induced hdm2alt1 in tumor and nontumorigenic cell lines correlating with p53 stability.
Dias CS; Liu Y; Yau A; Westrick L; Evans SC
Cancer Res; 2006 Oct; 66(19):9467-73. PubMed ID: 17018602
[TBL] [Abstract][Full Text] [Related]
2. An alternatively spliced HDM2 product increases p53 activity by inhibiting HDM2.
Evans SC; Viswanathan M; Grier JD; Narayana M; El-Naggar AK; Lozano G
Oncogene; 2001 Jul; 20(30):4041-9. PubMed ID: 11494132
[TBL] [Abstract][Full Text] [Related]
3. Genotoxic stress induces coordinately regulated alternative splicing of the p53 modulators MDM2 and MDM4.
Chandler DS; Singh RK; Caldwell LC; Bitler JL; Lozano G
Cancer Res; 2006 Oct; 66(19):9502-8. PubMed ID: 17018606
[TBL] [Abstract][Full Text] [Related]
4. Hodgkin's lymphoma cells express alternatively spliced forms of HDM2 with multiple effects on cell cycle control.
Sánchez-Aguilera A; García JF; Sánchez-Beato M; Piris MA
Oncogene; 2006 Apr; 25(18):2565-74. PubMed ID: 16331255
[TBL] [Abstract][Full Text] [Related]
5. Abundant expression of spliced HDM2 in Hodgkin lymphoma cells does not interfere with p14(ARF) and p53 binding.
Stürzenhofecker B; Schlott T; Quentin T; Kube D; Jung W; Trümper L
Leuk Lymphoma; 2003 Sep; 44(9):1587-96. PubMed ID: 14565663
[TBL] [Abstract][Full Text] [Related]
6. Identification of spliced variants of the proto-oncogene HDM2 in colorectal cancer.
Yu Z; Zhang B; Cui B; Wang Y; Han P; Wang X
Cancer; 2012 Feb; 118(4):1110-8. PubMed ID: 21761395
[TBL] [Abstract][Full Text] [Related]
7. ROS and p53 in regulation of UVB-induced HDM2 alternative splicing.
Tong L; Wu S
Photochem Photobiol; 2015; 91(1):221-4. PubMed ID: 24986024
[TBL] [Abstract][Full Text] [Related]
8. UV-radiation induces dose-dependent regulation of p53 response and modulates p53-HDM2 interaction in human fibroblasts.
Latonen L; Taya Y; Laiho M
Oncogene; 2001 Oct; 20(46):6784-93. PubMed ID: 11709713
[TBL] [Abstract][Full Text] [Related]
9. Stress-induced alternative splice forms of MDM2 and MDMX modulate the p53-pathway in distinct ways.
Jacob AG; Singh RK; Comiskey DF; Rouhier MF; Mohammad F; Bebee TW; Chandler DS
PLoS One; 2014; 9(8):e104444. PubMed ID: 25105592
[TBL] [Abstract][Full Text] [Related]
10. A novel mouse model of rhabdomyosarcoma underscores the dichotomy of MDM2-ALT1 function in vivo.
Comiskey DF; Jacob AG; Sanford BL; Montes M; Goodwin AK; Steiner H; Matsa E; Tapia-Santos AS; Bebee TW; Grieves J; La Perle K; Boyaka P; Chandler DS
Oncogene; 2018 Jan; 37(1):95-106. PubMed ID: 28892044
[TBL] [Abstract][Full Text] [Related]
11. Nuclear and cytoplasmic degradation of endogenous p53 and HDM2 occurs during down-regulation of the p53 response after multiple types of DNA damage.
Joseph TW; Zaika A; Moll UM
FASEB J; 2003 Sep; 17(12):1622-30. PubMed ID: 12958168
[TBL] [Abstract][Full Text] [Related]
12. MEK-ERK signaling controls Hdm2 oncoprotein expression by regulating hdm2 mRNA export to the cytoplasm.
Phelps M; Phillips A; Darley M; Blaydes JP
J Biol Chem; 2005 Apr; 280(17):16651-8. PubMed ID: 15723837
[TBL] [Abstract][Full Text] [Related]
13. BCL11B tumor suppressor inhibits HDM2 expression in a p53-dependent manner.
Obata M; Kominami R; Mishima Y
Cell Signal; 2012 May; 24(5):1047-52. PubMed ID: 22245141
[TBL] [Abstract][Full Text] [Related]
14. Human lymphoblastoid cell lines expressing mutant p53 exhibit decreased sensitivity to cisplatin-induced cytotoxicity.
Piovesan B; Pennell N; Berinstein NL
Oncogene; 1998 Nov; 17(18):2339-50. PubMed ID: 9811465
[TBL] [Abstract][Full Text] [Related]
15. hnRNP K: an HDM2 target and transcriptional coactivator of p53 in response to DNA damage.
Moumen A; Masterson P; O'Connor MJ; Jackson SP
Cell; 2005 Dec; 123(6):1065-78. PubMed ID: 16360036
[TBL] [Abstract][Full Text] [Related]
16. Nucleolar p14(ARF) overexpression in Reed-Sternberg cells in Hodgkin's lymphoma: absence of p14(ARF)/Hdm2 complexes is associated with expression of alternatively spliced Hdm2 transcripts.
García JF; Villuendas R; Sánchez-Beato M; Sánchez-Aguilera A; Sánchez L; Prieto I; Piris MA
Am J Pathol; 2002 Feb; 160(2):569-78. PubMed ID: 11839577
[TBL] [Abstract][Full Text] [Related]
17. Identification of an aberrantly spliced form of HDMX in human tumors: a new mechanism for HDM2 stabilization.
Giglio S; Mancini F; Gentiletti F; Sparaco G; Felicioni L; Barassi F; Martella C; Prodosmo A; Iacovelli S; Buttitta F; Farsetti A; Soddu S; Marchetti A; Sacchi A; Pontecorvi A; Moretti F
Cancer Res; 2005 Nov; 65(21):9687-94. PubMed ID: 16266988
[TBL] [Abstract][Full Text] [Related]
18. Intrinsic ubiquitination activity of PCAF controls the stability of the oncoprotein Hdm2.
Linares LK; Kiernan R; Triboulet R; Chable-Bessia C; Latreille D; Cuvier O; Lacroix M; Le Cam L; Coux O; Benkirane M
Nat Cell Biol; 2007 Mar; 9(3):331-8. PubMed ID: 17293853
[TBL] [Abstract][Full Text] [Related]
19. A small synthetic peptide, which inhibits the p53-hdm2 interaction, stimulates the p53 pathway in tumour cell lines.
Chène P; Fuchs J; Bohn J; García-Echeverría C; Furet P; Fabbro D
J Mol Biol; 2000 May; 299(1):245-53. PubMed ID: 10860736
[TBL] [Abstract][Full Text] [Related]
20. The Involvement of Splicing Factor hnRNP A1 in UVB-induced Alternative Splicing of hdm2.
Feng J; Li L; Tong L; Tang L; Wu S
Photochem Photobiol; 2016 Mar; 92(2):318-324. PubMed ID: 26757361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]